Next Article in Journal
Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder
Next Article in Special Issue
Radiosynthesis and Preclinical Evaluation of an 18F-Labeled Triazolopyridopyrazine-Based Inhibitor for Neuroimaging of the Phosphodiesterase 2A (PDE2A)
Previous Article in Journal
Resveratrol from Dietary Supplement to a Drug Candidate: An Assessment of Potential
Previous Article in Special Issue
Longitudinal Consumption of Ergothioneine Reduces Oxidative Stress and Amyloid Plaques and Restores Glucose Metabolism in the 5XFAD Mouse Model of Alzheimer’s Disease
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(8), 958; https://doi.org/10.3390/ph15080958
Action Date Notes Link
article xml file uploaded 2 August 2022 10:44 CEST Original file -
article xml uploaded. 2 August 2022 10:44 CEST Update https://www.mdpi.com/1424-8247/15/8/958/xml
article pdf uploaded. 2 August 2022 10:44 CEST Version of Record https://www.mdpi.com/1424-8247/15/8/958/pdf
article supplementary file uploaded. 2 August 2022 10:44 CEST - https://www.mdpi.com/1424-8247/15/8/958#supplementary
article html file updated 2 August 2022 10:45 CEST Original file -
article html file updated 13 August 2022 05:08 CEST Update https://www.mdpi.com/1424-8247/15/8/958/html
Back to TopTop